New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States

Oct.11.2022
New Study Shows Little Progress in Keeping Youth Away from Electronic Cigarettes in the United States
The latest study on youth vaping in the US shows little progress in preventing teens from using e-cigarettes.

A new study conducted by the US government on the use of e-cigarettes among youth has shown little progress in keeping teenagers away from vaping. The survey, which was released on Thursday, suggests that more high school students are using e-cigarettes, with 14% of them reporting recent use compared to 11% in the previous year.


However, experts warn that changes in the survey make comparisons difficult: this year, there is a much higher proportion of participants surveyed in schools, and there are often more reports of e-cigarette use in schools than at home. "Assessing trends (in e-cigarette use) since the outbreak of the pandemic remains difficult," said Alyssa Harlow, a researcher at the University of Southern California who studies adolescent e-cigarette use.


Although there are still many young people using e-cigarettes, they don't seem to be as popular as before. In 2019, 28% of high school students reported having recently used e-cigarettes. For educators, e-cigarettes remain a major issue.


Interestingly, the 2021-22 academic year is worse than pre-pandemic times, according to Mike Rinaldi, the principal of Westhill High School in Connecticut. He notes that it is the first year for many students returning from remote learning during the pandemic and speculates that some may have turned to e-cigarettes to cope with pandemic-related mental health issues or stress. Matt Forker, principal of Stamford High School, says that kids vaping in school bathrooms and stairwells remains a "persistent challenge".


Researchers from the Centers for Disease Control and Prevention authored a new study based on an online survey conducted from January 18th to May 31st of approximately 28,000 American high school students. The study inquired about the use of electronic cigarettes and other vaping devices in the past 30 days. In addition to 14% of high schoolers reporting recent use of e-cigarettes, around 3% of middle schoolers reported having tried them. Among those who used e-cigarettes, approximately 28% reported daily use. Nearly 85% of young people using e-cigarettes used flavored products, with Puff Bar and Vuse being the most popular brands followed by Hyde and Smok.


After months of pressure from congressional members and parents, the US Food and Drug Administration (FDA) took action against the manufacturers of Puff Bar and Hyde on Thursday. The agency sent a warning letter to Puff Bar manufacturer, EVO Brands, stating that the company had not obtained permission to sell their products in the US and that they were being illegally sold. Only a few e-cigarette companies have received FDA approval, which is only granted to products that are beneficial to the health of adult smokers.


The agency also stated that following the denial of their FDA authorization application, they have instructed Magellan Technology, the manufacturer of Hyde, to withdraw their product from the market.


The FDA has been working to regulate the extensive e-cigarette industry, which includes both established and start-up companies. Regulatory agencies have faced criticism from Congress and anti-e-cigarette advocates as they have missed multiple deadlines and have been unable to make decisions on compliance applications for millions of e-cigarette products submitted by companies.


In the past three years, federal and state laws and regulations have increased the purchasing age for tobacco and e-cigarette products, and have banned almost all small e-cigarette flavors that are popular among teenagers.


Some children may have also been scared away by the outbreak of illnesses and deaths related to e-cigarettes in 2019 - most of whom were associated with additives in black market e-liquids containing THC, a chemical that can produce a marijuana-like high when inhaled.


A leader of an advocacy organization has stated that their efforts to combat youth vaping have not been progressing well. These figures "may not reflect the larger reality of youth e-cigarette use that we hear about every day from parents, teachers, pediatricians, and prevention experts who are dealing with this urgent and ongoing youth public health crisis," said the organization, which is made up of parents opposed to vaping, in a statement.


Earlier this summer, the U.S. Food and Drug Administration (FDA) attempted to ban products from leading e-cigarette manufacturer Juul due to concerns about potential health risks. However, after a court challenge, the effort was forced to be put on hold. In a survey conducted this year, approximately one-fifth of teenage e-cigarette users reported using Juul recently, although it is no longer the most popular brand. This is a significant shift from 2019 when over half of young people's most commonly used e-cigarette was Juul.


On the contrary, many young people have turned to electronic cigarettes that offer laboratory-manufactured nicotine, including Puff Bar, which is a loophole in the FDA supervision that was shut down by Congress this year. Despite obtaining new authorization for these products, the FDA missed the mid-July deadline to make decisions on most products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is intended solely for industry exchange and research.


Due to limitations in translation abilities, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and positions.


The compilation of information is subject to the ownership of the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15